NKGen Biotech, Inc.: Nasdaq/NYSE listing notice — NKGen Biotech receives Nasdaq MVLS deficiency notice; 180-day cure period until Sep 9, 2024

NKGen Biotech, Inc.

Received Nasdaq Staff notice on March 11, 2024, for MVLS below $50M minimum for 30 consecutive business days.
Must regain compliance by Sep 9, 2024; if MVLS >= $50M for 10 consecutive business days, notice will be closed.
Company's market cap exceeded $50M on March 11, 2024 after the notice; evaluating actions to regain compliance.
If not compliant by Sep 9, common stock may be delisted; company may appeal or apply to transfer to Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

NKGen Biotech, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(A), 5810(c)(3)(C)

Exact text from the filing

March 11, 2024, NKGen Biotech, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company’s Market Value of Listed Securities (as defined under Nasdaq rules) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), Nasdaq has

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-24-035067

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.